Temporal changes within the (bladder) tumor microenvironment that accompany the therapeutic effects of the immunocytokine NHS-IL12

Temporal changes within the (bladder) tumor microenvironment that accompany the therapeutic effects of the immunocytokine NHS-IL12

Abstract Background While significant strides in the treatment of metastatic bladder cancer have been made with immune checkpoint inhibitors, the treatment of carcinoma in situ and non-muscle invasive, non-metastatic (superficial) human urothelial carcinoma, also termed non-muscle invasive bladder c...

Full description

Bibliographic Details
Main Authors: Y. Maurice Morillon, Zhen Su, Jeffrey Schlom, John W. Greiner
Format: Article
Language:English
Published: BMJ Publishing Group 2019-06-01
Series:Journal for ImmunoTherapy of Cancer
Subjects:
Non-muscle invasive bladder cancer
Immunotherapy
NHS-muIL12
Online Access:http://link.springer.com/article/10.1186/s40425-019-0620-2

Internet

http://link.springer.com/article/10.1186/s40425-019-0620-2

Similar Items